Brief: Enveric Biosciences Announces Positive Pharmacology And Safety Data For Lead Product, EB-003
15/10/2024 13:13
Oct 15 (Reuters) - Enveric Biosciences Inc ENVB.O :
* ENVERIC BIOSCIENCES: ANNOUNCES POSITIVE PHARMACOLOGY AND
SAFETY
DATA FOR LEAD PRODUCT, EB-003
Source text for Eikon: ID:nBw1WBWy4a
Further company coverage: ENVB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enveric Biosciences
See all newsBrief: Enveric Biosciences Announces Positive Results From IND-Enabling ADMET Studies
Enveric Biosciences Q2 net loss widens
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Brief: Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003
Brief: Enveric Biosciences Reports Positive Preclinical Results From Phototoxicity Analysis For Lead Neuroplastogen Candidate Eb-003